Balchem Executive Compensation (FY25)
BCPC · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025 ◇ Ted Harris | Latest say-on-pay support = June 18, 2026 | Chief executive pay ratio ◇ To the median employee |
Free for 3 days · no card
See how Balchem’s pay stands against its peers
- Balchem's company dashboard and its AI-written, board-ready brief, every figure cited to the filing
- Where Balchem sits against its disclosed peer group, with custom peer reruns and governance screens
- Every other company we cover, with alerts when they file
No card. Nothing is charged, and the trial ends on its own. After the trial: $499/month, or $5,000/year, about two months free.
Velarion Intel, $499/month, or $5,000/year, about two months free: one seat · every company we cover · 7-day refund, with dashboards, peer screens and board-ready briefs.
The Balchem brief, $299
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $449.
Data as of November 11, 2026Latest filing (8-K): June 22, 2026
12 filings cited on this page
Method: intel.velarion.ai/methodology
If a report fails to generate we keep working until you have it. No refunds on one-time reports.
Published by Velarion Company Intelligence
Velarion Intel, one year, every company
292 figures on this page: 282 cited to the filing that reported them, 10 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Ted Harris: $6,872,769 → $7,894,874 (14.9% higher)
Say-on-pay support: 93.8% → 98.0% (4.2 points higher)
CEO pay ratio: 198:1 → 135:1 (31.8% lower)
Frequently asked questions
Answers drawn from the data on this page.
Who is Balchem's chief executive and what were they paid?
Ted Harris, Chairman, President and Chief Executive Officer, received $7,894,874 in total compensation for fiscal 2025. Compared with the $6,872,769 reported for fiscal 2024, Harris' total was 14.9% higher.
What was Balchem's say-on-pay result?
The say-on-pay proposal drew 98.0% of votes cast for or against in favor at the meeting held June 18, 2026 for fiscal 2025.
Which companies are in Balchem's peer group?
The disclosed peer group names Ashland Global Corp., Avient Corp., Azek Company, Cabot Corp. and Celsius Holdings, among others.
What is Balchem's chief executive pay ratio?
The company reported a chief executive pay ratio of 135:1 for fiscal 2025, against median employee compensation of $58,406.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Ted Harris Chairman, President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Martin Bengtsson Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Jim Hyde Former Senior Vice President and General Manager, Human Health and Nutrition Departed during or after this year | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Martin Reid Senior Vice President and Chief Supply Chain Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Jonathan Griffin Senior Vice President and General Manager, Animal Nutrition and Health | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Hatsuki Miyata Executive Vice President, General Counsel and Secretary | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Ted Harris Chairman, President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
C. Martin Bengtsson Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Frederic Boned Senior Vice President and General Manager, Human Nutrition and Health | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Hatsuki Miyata Executive Vice President, General Counsel and Secretary | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Ted Harris Chairman, President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
C. Martin Bengtsson Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Frederic Boned Senior Vice President and General Manager, Human Nutrition and Health | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Hatsuki Miyata Executive Vice President, Chief Legal Officer and Secretary | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Ted Harris Chairman, President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
C. Martin Bengtsson Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Hatsuki Miyata Executive Vice President, Chief Legal Officer and Secretary | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Frederic Boned Senior Vice President and General Manager, Human Nutrition and Health | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
M. Brent Tignor Senior Vice President and Chief Human Resources Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| C. Martin Bengtsson | PSU | ◇ | — | ◇ | — | — | — | ◇ |
| Frederic Boned | PSU | ◇ | — | ◇ | — | — | — | ◇ |
| Hatsuki Miyata | PSU | ◇ | — | ◇ | — | — | — | ◇ |
| M. Brent Tignor | PSU | ◇ | — | — | — | — | — | ◇ |
| Ted Harris | PSU | ◇ | — | ◇ | — | — | — | ◇ |
Fiscal 2022 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Ted Harris | Option | ◇ | — | ◇ | September 15, 2032 |
| Option | ◇ | — | ◇ | September 15, 2032 | |
| Option | ◇ | — | ◇ | September 15, 2032 | |
| Option | ◇ | — | ◇ | February 12, 2035 | |
| Option | ◇ | — | ◇ | February 8, 2034 | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | February 8, 2033 | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Martin Bengtsson | Option | ◇ | — | ◇ | February 12, 2035 |
| Option | ◇ | — | ◇ | February 8, 2034 | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | February 8, 2033 | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Hatsuki Miyata | Option | ◇ | — | ◇ | February 12, 2035 |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | February 8, 2034 | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | February 8, 2033 | |
| RSU | ◇ | ◇ | — | — | |
| Frederic Boned | Option | ◇ | — | ◇ | February 12, 2035 |
| Option | ◇ | — | ◇ | February 8, 2034 | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | February 8, 2033 | |
| RSU | ◇ | ◇ | — | — | |
| M. Brent Tignor | Option | ◇ | — | ◇ | February 12, 2035 |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | February 8, 2034 | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | February 8, 2033 | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Matthew Wineinger Lead independent director | ◇ | ◇ | — | — | — | — | ◇ |
Daniel Knutson | ◇ | ◇ | — | — | — | — | ◇ |
Kathleen Fish | ◇ | ◇ | — | — | — | — | ◇ |
Monica Vicente | ◇ | ◇ | — | — | — | — | ◇ |
David Fischer | ◇ | ◇ | — | — | — | — | ◇ |
Olivier Rigaud | ◇ | ◇ | — | — | — | — | ◇ |
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Lead independent director premium | ◇ |
| Audit committee chair | ◇ |
| Compensation committee chair | ◇ |
| Nominating and governance chair | ◇ |
Equity is delivered as restricted stock units.
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- Ashland Global Corp. symbol not shown
- Avient Corp. AVNT
- Azek Company AZEK
- Cabot Corp. CBT
- Celsius Holdings CELH
- CSW Industrials CSW
- Element Solutions ESI
- FMC Corp. FMC
- H.B. Fuller Co. FUL
- Hain Celestial Group HAIN
- Hexcel HXL
- Ingevity Corp. NGVT
- Innospec Inc. IOSP
- J&J Snack Foods Corp. JJSF
- Lancaster Colony Corp. symbol not shown
- MGP Ingredients MGP
- Minerals Technologies MTX
- Quaker Chemical Corp. KWR
- Sensient Technologies SXT
- Stepan Co. S
- The Simply Good Foods Co. SMPL
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | June 18, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | June 18, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | June 20, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | June 23, 2023 | = | ◇ | ◇ | ◇ |
| 2020 | June 17, 2021 | = | ◇ | ◇ | ◇ |
| 2019 | June 18, 2020 | = | ◇ | ◇ | ◇ |
| 2018 | June 20, 2019 | = | ◇ | ◇ | ◇ |
| 2017 | June 20, 2018 | = | ◇ | ◇ | ◇ |
| 2016 | June 13, 2017 | = | ◇ | ◇ | ◇ |
| 2015 | June 15, 2016 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Ask our research desk — $99, 24h, every figure cited to its filing.
Sample answer — “What is the CEO’s total compensation?”
- Ted Harris (Chairman, President and Chief Executive Officer), FY2025 total compensation $7,894,874 (base salary $1,198,269) [exec_comp, SEC accession 0001140361-26-017099, filed 2026-04-27]What this page does not include
Everything above is a fact Balchem disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Balchem sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $299Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $299Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $299Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
292 figures on this page: 282 cited to the filing that reported them, 10 calculated from figures it prints.
282 cited to the filing
10 calculated from the filing
Documents cited
- 0001140361-26-025971
- 0001140361-26-0170992025 Grants of Plan-Based Awards · CEO Pay Ratio · Director Compensation · Outstanding Equity Awards at Fiscal Year End 2025 · and 1 more section
- 0001140361-25-023176
- 0001140361-24-031096Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001140361-23-021578Summary Compensation Table
- 0001140361-22-024070Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001140361-21-021535Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001140361-20-014524Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001140361-19-011323Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001140361-18-029501Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001140361-17-025251Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001140361-16-070283Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Balchem executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/BCPC (accessed 2026).
Short form: data: Velarion
The Balchem brief, $299
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $449.
12 filings cited on this page
Method: intel.velarion.ai/methodology
If a report fails to generate we keep working until you have it. No refunds on one-time reports.
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Balchem and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Peers Balchem discloses
The companies named in BCPC's own disclosed peer group.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}